Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients
Identifying triggers and aggravating factors is crucial for effective ACH treatment. We suggest that biologics may be a useful first-line treatment option for clinicians managing ACH.
Authors
- Bin Yang (ORCID: https://orcid.org/0000-0002-7155-6079)
- Yanqiang Shi (ORCID: https://orcid.org/0000-0003-0814-6322)
- Xiaohua Wang (ORCID: https://orcid.org/0000-0001-6036-7945)
- Xiaoling Yu (ORCID: https://orcid.org/0000-0002-3753-4984)
- Liyan Yuan (ORCID: https://orcid.org/0009-0009-4201-1705)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1080/09546634.2024.2434098
- Citations
- 5
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- National Natural Science Foundation of China